In conclusion, EGCG treatment activated the TrkA signaling, inhibited the p75NTR signaling, and adjusted the TrkA/p75NTR imbalance by increasing the NGF relative expression in APP/PS1 mice to ameliorate the behavioral deficits and amyloidosis. Here, NGF is linked to amyloidosis.